Resilience, by design
Sterile injectables are essential. So is earning your trust as a dependable U.S.-based partner.
But no one can solve this challenge alone.
Join us in building a stronger, more resilient sterile injectables market.
Learn more at PfizerHospitalUS.com/supply-sustainability.
Reference: 1. Data on file.
PP-UNP-USA-6656 © 2025 Pfizer Inc. All rights reserved. July 2025
Read more about
Pfizer's commitment
Over the past decade, Pfizer has invested more than $2 billion to modernize and expand our 6 U.S. based
sterile injectables manufacturing and distribution sites. Our domestic footprint, bolstered by our global
manufacturing network, produces nearly 475 million units annually for the U.S. market. This robust and
resilient infrastructure enables us to respond rapidly in times of patient need. At Pfizer, our commitment
to resilience is not just a talking point, it's a core strategy—one that has earned us the prestigious
Diamond Badge from the Healthcare Industry Resilience Collaborative (HIRC).
1
